Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Samulski

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Current Opinion in Genetics & Development|February 1, 1993
Adeno-associated virus: integration at a specific chromosomal locusR J Samulski
Molecular Biotechnology|February 1, 1995
AAV as a viral vector for human gene therapy. Generation of recombinant virusF Rolling, R J Samulski
Journal of Virology|January 1, 1988
Adenovirus E1B 55-Mr polypeptide facilitates timely cytoplasmic accumulation of adeno-associated virus mRNAsR J Samulski, T Shenk
Current Opinion in Biotechnology|November 20, 1998
Adeno-associated virus expression systems for gene transferJ E Rabinowitz, J Samulski
Journal of Virology|January 28, 1998
Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virionsC Summerford, R J Samulski
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2001
Adeno-associated virus (AAV) site-specific recombination does not require a Rep-dependent origin of replication within the AAV terminal repeatS M Young, R J Samulski
Methods in Molecular Medicine|February 5, 2014
Methods for the construction and propagation of recombinant adeno-associated virus vectorsJ S Bartlett, R J Samulski
Journal of Virology|July 15, 2005
Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry stepsJoshua C Grieger, Richard J Samulski
Molecular Medicine Today|November 14, 2000
Adeno-associated virus vectors for gene therapy: more pros than cons?P E Monahan, R J Samulski
Gene Therapy|February 19, 2000
AAV vectors: is clinical success on the horizon?P E Monahan, R J Samulski
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Current Opinion in Genetics & Development|February 1, 1993
Adeno-associated virus: integration at a specific chromosomal locusR J Samulski
Molecular Biotechnology|February 1, 1995
AAV as a viral vector for human gene therapy. Generation of recombinant virusF Rolling, R J Samulski
Journal of Virology|January 1, 1988
Adenovirus E1B 55-Mr polypeptide facilitates timely cytoplasmic accumulation of adeno-associated virus mRNAsR J Samulski, T Shenk
Current Opinion in Biotechnology|November 20, 1998
Adeno-associated virus expression systems for gene transferJ E Rabinowitz, J Samulski
Journal of Virology|January 28, 1998
Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virionsC Summerford, R J Samulski
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2001
Adeno-associated virus (AAV) site-specific recombination does not require a Rep-dependent origin of replication within the AAV terminal repeatS M Young, R J Samulski
Methods in Molecular Medicine|February 5, 2014
Methods for the construction and propagation of recombinant adeno-associated virus vectorsJ S Bartlett, R J Samulski
Journal of Virology|July 15, 2005
Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry stepsJoshua C Grieger, Richard J Samulski
Molecular Medicine Today|November 14, 2000
Adeno-associated virus vectors for gene therapy: more pros than cons?P E Monahan, R J Samulski
Gene Therapy|February 19, 2000
AAV vectors: is clinical success on the horizon?P E Monahan, R J Samulski
Pageof 13